RT Journal Article
SR Electronic
T1 Speech and language impairments in behavioral variant frontotemporal dementia: A systematic review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.10.21260313
DO 10.1101/2021.07.10.21260313
A1 Amandine Geraudie
A1 Petronilla Battista
A1 Adolfo M. García
A1 Isabel E. Allen
A1 Zachary A. Miller
A1 Maria Luisa Gorno-Tempini
A1 Maxime Montembeault
YR 2021
UL http://medrxiv.org/content/early/2021/07/12/2021.07.10.21260313.abstract
AB Although behavioral variant frontotemporal dementia (bvFTD) is classically defined by behavioral and socio-emotional changes, impairments often extend to other cognitive functions. These include early speech and language deficits related to the disease’s core neural disruptions. Yet, their scope and clinical relevance remains poorly understood. This systematic review characterizes such disturbances in bvFTD, considering clinically, neuroanatomically, genetically, and neuropathologically defined subgroups. We included 181 experimental studies, with at least 5 bvFTD patients diagnosed using accepted criteria, comparing speech and language outcomes between bvFTD patients and healthy controls or between bvFTD subgroups. Results reveal extensive and heterogeneous deficits across cohorts, with (a) consistent lexico-semantic, orthographic, and prosodic impairments; (b) inconsistent deficits in motor speech and grammar; and (c) relative preservation of phonological skills. Also, preliminary findings suggest that the severity of speech and language deficits might be associated with global cognitive impairment, predominantly temporal or fronto-temporal atrophy and MAPT mutations (vs C9orf72). Although under-recognized, these impairments contribute to patient characterization and phenotyping, while potentially informing diagnosis and prognosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAG received an internship grant from the French Society of Neurology. AMG is supported by CONICET; ANID, FONDECYT Regular [grant numbers 1210176 and 1210195]; Programa Interdisciplinario de Investigación Experimental en Comunicación y Cognición (PIIECC), Facultad de Humanidades, USACH. MM is supported by postdoctoral funding from Canadian Institutes of Health Research (CIHR) and Fonds Québécois de Recherche en Santé (FRQS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available on request.